Raffles Medical Group (RMG) is a private healthcare provider in Asia, operating in Singapore, China, Japan, Vietnam and Cambodia. It has a network of clinics with family physicians, specialists and dental surgeons, and owns Raffles Hospital, a tertiary care hospital in Singapore, which accommodates surgical centres, medical laboratories and 24 specialist centres in various areas like Obstetrics & Gynaecology, Cardiology, Oncology and Orthopaedics. RMG has a market capitalization of around $3B and the latest FY22 results have been reasonably good. Revenue grew by 6% to $767M and profit grew by 72% to $144M. Earnings per share grew 72% to 8c, while Net Assets Value grew 6% to 55c. A final divdend of 3.8c has been declared and will xd on 9 May. Taking a closer look at its P&L, shows the strong increase in profit came mainly from a sharp drop in Staff costs ($45M) and Inventories and consumables used ($21M)....